Nalaganje...
Next generation immune-checkpoints for cancer therapy
The discovery and clinical application of immune-checkpoint inhibitors has dramatically improved the treatments, outcomes and therapeutic concepts in multiple tumor settings. This breakthrough was mainly based on monoclonal antibodies blocking the inhibitory molecule CTLA-4 and or the PD-1/PD-L1 axi...
Shranjeno v:
| izdano v: | J Thorac Dis |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
AME Publishing Company
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5994499/ https://ncbi.nlm.nih.gov/pubmed/29951308 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2018.02.79 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|